Patents by Inventor Suok Su KIM

Suok Su KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11634740
    Abstract: The present invention provides: a novel allulose epimerase variant in which an amino acid residue present at a specific position of an amino acid sequence of a wild-type D-allulose 3-epimerase derived from Flavonifractor plautii is substituted with another amino acid residue; and various uses of the novel allulose epimerase variant. The novel allulose epimerase variant according to the present invention has a higher conversion rate of fructose to allulose compared to that of the wild-type D-allulose 3-epimerase derived from Flavonifractor plautii, and has excellent thermal stability especially under high temperature conditions of 60° C. or higher, and thus can prevent contamination during an industrial-scale enzymatic conversion reaction for the mass production of allulose, shorten production time, and reduce production costs.
    Type: Grant
    Filed: April 27, 2021
    Date of Patent: April 25, 2023
    Assignee: DAESANG CORPORATION
    Inventors: Hyung Seop Youn, Eun Seok Choi, Ji Ha Lee, Suok Su Kim, Seung Woo Cho, Tae Yong Kim, Hak Jun Kim
  • Publication number: 20230055400
    Abstract: The present invention provides: a novel allulose epimerase variant in which an amino acid residue present at a specific position of an amino acid sequence of a wild-type D-allulose 3-epimerase derived from Flavonifractor plautii is substituted with another amino acid residue; and various uses of the novel allulose epimerase variant. The novel allulose epimerase variant according to the present invention has a higher conversion rate of fructose to allulose compared to that of the wild-type D-allulose 3-epimerase derived from Flavonifractor plautii, and has excellent thermal stability especially under high temperature conditions of 60° C. or higher, and thus can prevent contamination during an industrial-scale enzymatic conversion reaction for the mass production of allulose, shorten production time, and reduce production costs.
    Type: Application
    Filed: April 27, 2021
    Publication date: February 23, 2023
    Applicant: DAESANG CORPORATION
    Inventors: Hyung Seop YOUN, Eun Seok CHOI, Ji Ha LEE, Suok Su KIM, Seung Woo CHO, Tae Yong KIM, Hak Jun KIM
  • Publication number: 20220307062
    Abstract: The present invention provides a novel allulose epimerase variant and various uses thereof, in which glycine (Gly), an amino acid residue at position 216 of the amino acid sequence of wild-type D-allulose 3-epimerase derived from Flavonifractor plautii, is substituted with serine (Ser). The novel allulose epimerase variant according to the present invention has a higher conversion activity of fructose to allulose compared to the wild-type D-allulose 3-epimerase derived from Flavonifractor plautii, and in particular, it has excellent thermal stability under high temperature conditions of 60° C. or higher, so that the enzyme conversion reaction is performed at the industrial level for mass production of allulose to prevent contamination, to shorten production time, and to reduce production cost.
    Type: Application
    Filed: September 25, 2020
    Publication date: September 29, 2022
    Applicant: DAESANG CORPORATION
    Inventors: Hyung Seop YOUN, Eun Seok CHOI, Ji Ha LEE, Suok Su KIM
  • Publication number: 20220049212
    Abstract: The present disclosure relates to a mutant strain having enhanced L-glutamic acid productivity and a method of producing L-glutamic acid using the same. The mutant strain according to one embodiment of the present disclosure has reduced production of citramalate as a by-product due to weakening or inactivation of the activity of citramalate synthase and has excellent L-glutamic acid productivity. The strain having an additional mutation in the YggB protein may produce L-glutamic acid in an improved yield due to enhancement of glutamic acid release. Thus, when the mutant strain is used, it is possible to more effectively produce L-glutamic acid.
    Type: Application
    Filed: December 5, 2019
    Publication date: February 17, 2022
    Applicant: DAESANG CORPORATION
    Inventors: Hyun Young KIM, Sun Hee LEE, Hyun Ho KIM, Young II JO, Hyung Seop YOUN, Suok Su KIM